ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Dana-Farber Accepts Responsibility For Death Of One Patient, Harm To Another

March 31, 1995

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

Sen. Mack Calls For “National Crusade” Against Cancer.

May 26, 2000

ASSIST Gets Extra Year Of Funding While NCI Considers Role In Tobacco Control

January 17, 1997

Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980

October 12, 1979